Chemical Structure (Buprenorphine HCl Sublingual Tabs 1)
Buprenorphine Hcl Tablet
Product Images NDC 0406-7018
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hcl (NDC 0406-7018). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Specgx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Mouth Illustration (Buprenorphine HCl Sublingual Tabs 2)
Package Label Principal Display Panel (2 mg Tablets)
This text provides information about a medication called Buprenorphine, which comes in the form of tablets containing 2.16 mg of buprenorphine HCI, USP equivalent to 2 mg of buprenorphine base. It includes instructions for dosage, storage conditions, and cautions for children, as well as contact details for the manufacturer, SpecGx LLC. It also mentions the need to dispense the Medication Guide separately to each patient.*
Package Label Principal Display Panel (8 mg Tablet)
This text appears to be a medication description for Buprenorphine tablets, each containing 8.64 mg of buprenorphine HCI, USP equivalent to 8 mg of buprenorphine base. It contains information on dosage, storage conditions, distribution by pharmacists along with the warning to keep the medication out of reach of children due to the need for emergency medical care if accidentally ingested. The medication guide can be printed from the provided website.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
